本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bausch Health Companies Inc

4.66
-0.4450-8.73%
成交量:226.81万
成交额:1,071.64万
市值:17.20亿
市盈率:-37.24
高:5.11
开:5.08
低:4.59
收:5.10
数据加载中...

公司资料

公司名字:
Bausch Health Companies Inc
交易所:
NYSE
成立时间:
- -
员工人数:
20700
公司地址:
2150 St. ElzEar Boulevard West,Laval,Quebec,Canada
邮编:
H7L 4A8
电话:
传真:
- -
简介:
Bausch Health Companies Inc.是一家在加拿大不列颠哥伦比亚省注册的公司。该公司是一家跨国、专业制药和医疗器械公司,主要在胃肠病学和皮肤病学的治疗领域开发、制造和销售一系列广泛的品牌、非专利和品牌非专利药品、非处方药产品和医疗美容器械,并通过其对Bausch + Lomb Corporation约89%的所有权,在眼健康治疗领域开发品牌和品牌非专利药品、非处方药产品和医疗器械(隐形眼镜、人工晶状体、眼科手术设备)。该公司的产品直接或间接销往大约100个国家。

董事

名称
职位
Joseph C. Papa
Director, Chairman of the Board and Chief Executive Officer
Amy B. Wechsler
Independent Director
Andrew C. von Eschenbach
Independent Director
Argeris N. Karabelas
Independent Director
Brett M. Icahn
Independent Director
John A. Paulson
Independent Director
Richard U. De Schutter
Independent Director
Robert Hale
Independent Director
Robert N. Power
Independent Director
Russel C. Robertson
Independent Director
Sarah B. Kavanagh
Independent Director
Steven D. Miller
Independent Director
Thomas W. Ross, Sr.
Independent Director

股东

名称
职位
Joseph C. Papa
Director, Chairman of the Board and Chief Executive Officer
Paul S. Herendeen
Executive Vice President and Chief Financial Officer
Christina M. Ackermann
Executive Vice President, General Counsel and Head of Commercial Operations
Joseph F. Gordon
President & Co-Head Bausch + Lomb/International
Robert A. Spurr
President, Salix
Thomas J. Appio
President & Co-Head Bausch + Lomb/International